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a b s t r a c t
While alexithymia, or difﬁculties identifying and describing affect, has been commonly observed in
schizophrenia, little is known about its causes and correlates. To test the hypothesis that deﬁcits in
emotion identiﬁcation and expression result from, or are at least related to, deﬁcits in neurocognition
and affective symptoms, we assessed alexithymia using the Toronto Alexithymia Scale (TAS-20),
symptoms using the Positive and Negative Syndrome Scale (PANSS), and neurocognition using the
MATRICS battery among 65 adults with schizophrenia spectrum disorders in a non-acute phase of
illness. Partial correlations controlling for the effects of social desirability revealed that difﬁculty
identifying feelings and externally oriented thinking were linked with greater levels of neurocognitive
deﬁcits, while difﬁculty describing feelings was related to heightened levels of emotional distress. To
explore whether neurocognition and affective symptoms were uniquely related to alexithymia, a
multiple regression was conducted in which neurocognitive scores and affective symptoms were
allowed to enter to predict overall levels of alexithymia after controlling for social desirability. Results
revealed both processing speed and anxiety uniquely contributed to the prediction of the total score on
the TAS-20. Results suggest that dysfunctions in both cognitive and affective processes may be related to
alexithymia in schizophrenia independently of one another.
Published by Elsevier Ireland Ltd.
1. Introduction
Alexithymia refers to a range of interrelated difﬁculties, includ-
ing (a) identifying feelings and distinguishing between feelings
and bodily sensations of emotional arousal; (b) describing feelings
to others; (c) constricted imaginal processes; and (d) a stimulus-
bound, externally orientated cognitive style (Taylor et al., 1997). In
contrast to constructs such as mentalization and metacognition,
alexithymia focuses speciﬁcally on awareness and expression of
one's own emotions. Heightened levels of alexithymia in a number
of different schizophrenia samples (Stanghellini and Ricca, 1995;
Cedro et al., 2001; Todarello et al., 2005; Van’t Wout et al., 2007;
van der Meer et al., 2009; Koelkebeck et al., 2010; Kubota et al.,
2011) have led several authors to hypothesize that alexithymia
may be a vulnerability factor for the development of schizophrenia
(Van’t Wout et al., 2007; van der Meer et al., 2009), and more
speciﬁcally may be an underlying cause of social dysfunction
(Van’t Wout et al., 2007).
A range of studies has sought to better understand the presence
of alexithymia among persons with schizophrenia by examining
its links to other features of illness, particularly symptoms.
Stanghellini and Ricca (1995) found that patients with a predomi-
nantly non-paranoid, negative symptom presentation were sig-
niﬁcantly more likely to be identiﬁed as alexithymic compared to
those presenting primarily with paranoia, whereas Van’t Wout
et al. (2007) found that negative symptoms were linked with
deﬁcits in identifying feelings only. These authors also noted
greater alexithymia among male patients and among male ﬁrst-
degree relatives compared to control subjects. Examining alex-
ithymia and positive symptoms, Cedro et al. (2001) found alex-
ithymia to be more prevalent in persons with the paranoid
subtype of schizophrenia compared to matched healthy controls.
Other ﬁndings challenge the link between alexithymia and posi-
tive and negative symptoms. For instance, one study found that
negative symptoms abated during the course of one year while
alexithymia remained stable (Todarello et al., 2005). This study
also observed no signiﬁcant associations between alexithymia and
global psychopathology, positive symptoms, or depression. Similar
to others, van der Meer et al. (2009) again found that persons with
schizophrenia experienced more difﬁculties identifying their feel-
ings than others without psychosis, and noted that alexithymia
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was positively correlated with depression. Gender differences did
not emerge as signiﬁcant in this study. As a whole, this body of
work is equivocal and at best raises the possibility of a very
complicated relationship between alexithymia and symptoms.
Research has to our knowledge, however, yet to examine
neurocognition and alexithymia simultaneously in schizophrenia.
Neurocognitive deﬁcits have been commonly observed in schizo-
phrenia (Saykin et al., 1991), and there are several reasons to
think that they may be linked to alexithymia. Neurobiological
research suggests that persons with alexithymia have impaired
interhemispheric communication and may have brain structures
or functional circuits that are dysfunctional or deﬁcient (Larsen et
al., 2003; Taylor and Bagby, 2004; Wingbermühle et al., 2012).
Lane (2008) also proposes a neural model of alexithymia that has
some empirical support. In a nonclinical population, higher levels
of alexithymia have been associated with poorer neurocognitive
test performance, speciﬁcally poorer memory and nonverbal
intelligence (Onor et al., 2010). Among asymptomatic individuals
with HIV, greater alexithymia has been signiﬁcantly related to
poorer attention, working memory, spatial reasoning, and visuos-
patial organization (Bogdanova et al., 2010). Research on syn-
thetic metacognitive capacity, or the ability to form complex
representations of oneself and others, has found that unaware-
ness of one's emotions in schizophrenia is related to poorer
verbal memory, processing speed, and executive functioning
(Lysaker et al., 2011b), and those who lack the ability to
distinguish their own thoughts and feelings tend to have poorer
working memory (Lysaker et al., 2007). An improved under-
standing of the links between alexithymia and neurocognition
seems essential if we are to better understand how alexithymia
may develop and how it may be addressed in treatment, which
appears indicated given its associations with functional impairments
(Vanheule et al., 2010) and poor psychotherapeutic outcomes
(Ogrodniczuk et al., 2011).
To address this issue the current study has examined the
relationship of concurrent assessments of alexithymia, neurocog-
nition, and symptoms among a sample of persons with schizo-
phrenia spectrum disorders. Our primary prediction was that
greater levels of alexithymia would be related to poorer neuro-
cognition. Of note, we assessed a range of different neurocognitive
domains and considered the examination of each speciﬁc domain
to be exploratory in nature. In regard to symptoms, we predicted
that alexithymia would be positively and signiﬁcantly related to
depression and anxiety given repeated ﬁndings that alexithymia is
related to depressive and anxiety disorders (e.g., Parker et al.,
1993; Honkalampi et al., 1999; Marchesi et al., 2000, 2005;
Saarijarvi et al., 2001; Leweke et al., 2011). We did not anticipate
that alexithymia would be signiﬁcantly related to positive and
negative symptoms given the equivocal ﬁndings of previous
studies.
Of note, to assess alexithymia we used the Toronto Alexithymia
Scale-20 (TAS-20; Bagby et al., 1994a). While this is the most
utilized measure of alexithymia (Lumley, 2000; Bagby et al., 2006),
it is possible that scores would be biased by socially desirable
responding given that the TAS-20 is a self-report measure. Helmes
et al. (2008), for instance, found that among three samples of
undergraduate students, alexithymia as measured by the TAS-20
was signiﬁcantly and negatively related to socially desirable
responding. In particular, lower levels of alexithymia were sig-
niﬁcantly related to higher scores on a measure of social desir-
ability that taps unintentional, or unconscious, attempts to portray
oneself in a positive light. Given these ﬁndings and general
concerns about self-report, we included a measure of social
desirability to be used as a covariate in other analyses if necessary.
Finding Helmes et al. (2008) distinction between intentional and
unintentional socially desirable responding interesting, we utilized
a two-factor model of the Marlowe–Crowne Social Desirability
Scale (MCSDS; Crowne and Marlowe, 1960) that allowed for
similar distinctions.
2. Methods
2.1. Participants
Participants were 65 adults with diagnoses of schizophrenia (n¼42) or
schizoaffective disorder (n¼23), as conﬁrmed by the Structured Clinical Interview
for DSM-IV (SCID; Spitzer et al., 1994). Participants were enrolled as part of a larger
study on cognitive-behavioral therapy and work outcomes for persons with
schizophrenia spectrum disorders. All participants were recruited from a local
Veterans Affairs medical center and were in a post-acute phase of illness as deﬁned
by no hospitalizations and no changes in psychotropic medication or housing
within 30 days prior to enrollment. Other exclusion criteria included active
substance dependence, history of traumatic brain injury, and mental retardation,
which were determined through chart review and the SCID. On average (mean7-
standard deviation), participants were 50.54710.75 years old, had 12.7472.31
years of education, and had 5.0274.68 lifetime psychiatric hospitalizations, with
the ﬁrst occurring at age 29.66712.92. Thirty-six participants identiﬁed as African
American, 28 as Caucasian, and one as Latino. Sixty-one were male, and four were
female.
2.2. Instruments
2.2.1. The Toronto Alexithymia Scale
The Toronto Alexithymia Scale-20 (TAS-20; Bagby et al., 1994a) is a 20-item
self-report measure of alexithymia. Items are rated using a ﬁve-point Likert scale,
with participants indicating level of agreement with statements that assess both
the affective and cognitive elements of the alexithymia construct. Total scores
range from 20 to 100, with higher scores indicating greater degree of alexithymia.
Though the present study analyzed alexithymia as a dimensional construct, it has
been suggested that scores exceeding 60 are indicative of clinically signiﬁcant
alexithymia (Taylor and Taylor, 1997). In addition to a total score, the TAS-20 yields
three factor scores: difﬁculty identifying feelings, difﬁculty describing feelings, and
externally oriented thinking. Evidence of acceptable internal consistency, test–
retest reliability, and construct, concurrent, and convergent validity has been
reported (Bagby et al., 1994a, 1994b). For this study sample, acceptable internal
consistency was found using Cronbach's alpha (α¼0.75). Research suggests the
TAS-20 is appropriate for use with persons from a variety of backgrounds (Parker et
al., 2003).
2.2.2. The Positive and Negative Syndrome Scale
The Positive and Negative Syndrome Scale (PANSS; Kay et al., 1987) is a 30-item
rating scale scored by trained research staff following chart-review and a semi-
structured interview. Items are rated on a scale ranging from one to seven, with
higher scores reﬂective of greater symptom severity. A series of studies summar-
ized by Kay et al. (1987) supports the construct, convergent, and discriminant
validity of the PANSS. For this study, we utilized three of ﬁve factor-analytically
derived components: positive symptoms, negative symptoms, and emotional
discomfort. The emotional discomfort component contains items that assess
anxiety, depressed mood, guilt, and active social avoidance. Good to excellent
intraclass correlations for each scale and most items suggest reliable symptom
assessment using the factor components (Bell et al., 1994). For this study,
assessment of inter-rater reliability was found to be high to excellent with
intraclass correlations for blind raters observing the same interview ranging from
0.84 to 0.93. To reduce the overall number of correlations produced in this study,
the cognitive and hostility components were not examined given a lack of
predictions regarding the relationships between these factors and alexithymia.
2.2.3. The Measurement and Treatment Research to Improve Cognition in
Schizophrenia
The Measurement and Treatment Research to Improve Cognition in Schizo-
phrenia (MATRICS; Nuechterlein et al., 2008) is a widely used standard battery for
measuring cognition in schizophrenia. It consists of ten tests that assess seven
cognitive domains, including processing speed, attention/vigilance, verbal and
nonverbal working memory, verbal learning, visual learning, reasoning and
problem solving, and social cognition. Individual tests were selected for their high
reliability and validity, and the measure as a whole is also reliable and valid for
generating a composite score for cognitive functioning.
2.2.4. The Marlowe–Crowne Social Desirability Scale
The Marlowe–Crowne Social Desirability Scale (MCSDS; Crowne and Marlowe,
1960) is a 33-item self-report measure that prompts participants to indicate if
questions about their experiences are true or false. Items include culturally
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sanctioned behaviors that are nonetheless unlikely to occur. Higher scores suggest
a need to obtain approval by responding in what is perceived as a culturally
approved manner. Ventimiglia and MacDonald (2012) proposed a two-factor model
of the MCSDS that includes impression management (IM) and self-deception (SD).
IM reﬂects efforts to knowingly respond in a manner that creates a favorable self-
representation for others, whereas SD reﬂects a socially naïve self-image that does
not involve deliberate misrepresentation of one's self. Ventimiglia and MacDonald
(2012) reported an adequate Cronbach's alpha for IM (α¼0.65) and a weak
reliability coefﬁcient for SD (α¼0.51). In another sample, items from IM yielded a
satisfactory reliability coefﬁcient (α¼0.85) and items from SD demonstrated an
adequate Cronbach's alpha (α¼0.60) (Guerrero and Lysaker, 2013).
2.3. Procedures
All procedures were approved by the appropriate research review committees.
Following written informed consent, the SCID was administered by a clinical
psychologist in order to conﬁrm diagnoses and assess exclusion criteria. Partici-
pants then completed a demographic questionnaire and an assessment battery that
included the measures for this study. Measures were administered in a random
order by a trained research assistant who held at minimum a Bachelor's degree.
PANSS ratings were performed blind to responses on other measures. Though
participants underwent additional procedures as part of the larger study on
cognitive-behavioral therapy, all data utilized for the present study was derived
from the baseline assessment prior to any intervention.
2.4. Analyses
Analyses were planned in four stages. First, we planned to assess whether
demographic variables and response style on the MCSDS were signiﬁcantly related
to TAS-20 scores. If so, we planned to use these variables as covariates in
subsequent analyses. Second, we planned to examine whether TAS-20 scores were
signiﬁcantly related to MATRICS and PANSS component scores. Third, we planned
to determine if TAS-20 scores were signiﬁcantly related to speciﬁc PANSS
symptoms if the parent PANSS component score was signiﬁcantly related to
alexithymia. Given the number of planned correlations, we reduced alpha to
0.025 and chose to utilize two-tailed tests despite unidirectional hypotheses.
Fourth, if there was evidence of signiﬁcant relationships between alexithymia
and response style, neurocognition, and symptoms, we planned to conduct multi-
ple regressions to determine the extent to which these variables predicted
alexithymia scores.
3. Results
Means and standard deviations for all key variables are pre-
sented in Table 1. Univariate correlations revealed that age was
unrelated to TAS-20 factor scores and total score (r¼0.13, p¼0.29;
r¼0.04, p¼0.75; r¼0.17, p¼0.17; r¼0.14, p¼0.27), as was educa-
tion (r¼0.11, p¼0.42; r¼0.14, p¼0.27; r¼0.14, p¼0.27;
r¼0.15, p¼0.24). T tests revealed that TAS-20 total scores and
three subscales did not differ between men and women (t¼0.77,
p¼0.44; t¼0.50, p¼0.62; t¼1.29, p¼0.20; t¼0.14, p¼0.89) or
between participants with schizophrenia or schizoaffective dis-
order (t¼1.52, p¼0.14; t¼0.98, p¼0.33; t¼0.82, p¼0.42; t¼1.14,
p¼0.17). The impression management factor from the MCSDS was
positively and signiﬁcantly related to TAS-20 total (r¼0.53,
p¼0.0001) and all TAS-20 factor scores (r¼0.50, p¼0.0001;
r¼0.47, p¼0.0001; r¼ .35, p¼0.005). The self-deception factor
from the MCSDS was positively and signiﬁcantly related to TAS-20
Factor 1 (r¼0.38, p¼0.002), Factor 2 (r¼0.27, p¼0.03) and TAS-20
total (r ¼0.35, p¼0.004). No signiﬁcant links were found between
self-deception and the TAS-20 Factor 3 score (r¼0.16, p¼0.19).
Given these ﬁndings, impression management (i.e., deliberate
favorable self-representation) was utilized as a covariate in sub-
sequent analyses.
Next, a series of Pearson correlations was utilized to test
hypotheses about the potential relationships between alexithymia
and symptoms and neurocognition. While controlling for impres-
sion management, a number of signiﬁcant relationships emerged
that were generally consistent with our predictions. These ﬁndings
are displayed in Table 2. Of note, both neurocognitive performance
and select symptoms were signiﬁcantly related to difﬁculty
identifying feelings and overall level of alexithymia. Examining
the Emotional Discomfort component of the PANSS in more detail
revealed signiﬁcant and positive relationships between anxiety
and difﬁculty identifying feelings (r¼0.36, p¼0.002), depression
and difﬁculty identifying feelings (r¼0.46, p¼0.000), and no
signiﬁcant relationships with either guilt or active avoidance with
difﬁculty identifying feelings (r¼0.04, p¼0.73; r¼0.22, p¼0.08,
respectively).
Finally, to determine whether signiﬁcant correlates were
uniquely predictive of difﬁculty identifying feelings and total level
of alexithymia, two stepwise multiple regressions were conducted.
In these analyses impression management was always entered in
the ﬁrst step in order to control for potential response bias.
As summarized in Table 3, these analyses revealed that greater
difﬁculty identifying feelings was predicted by greater efforts at
impression management, poorer working memory, more severe
Table 1
Descriptive statistics for response style, alexithymia, symptoms, and neurocogni-
tion (N¼65).
Instrument Factor Mean Standard deviation
MCSDS Impression management 2.88 2.05
Self-deception 7.72 1.31
TAS-20 Difﬁculty identifying feelings 20.43 6.20
Difﬁculty describing feelings 15.66 3.76
Externally oriented thinking 22.17 3.49
Total 58.26 11.43
MATRICS Processing speed 31.54 10.46
Attention 35.15 9.72
Working memory 34.05 10.42
Verbal memory 35.34 8.29
Visual memory 33.38 10.44
Abstract reasoning 37.38 6.39
Social cognition 35.71 11.87
Composite 24.89 10.24
PANSS Positive symptoms 18.37 5.04
Negative symptoms 19.85 5.08
Emotional discomfort
Anxiety 3.20 1.20
Depression 3.57 1.61
Guilt 1.86 1.28
Active avoidance 3.52 1.25
Table 2
Correlations of alexithymia and symptoms and neurocognition while controlling
for impression management (N¼65).
TAS-20
Factor 1
TAS-20
Factor 2
TAS-20
Factor 3
TAS-20
Total
PANSS components
Positive symptoms 0.19 0.07 0.16 0.08
Negative symptoms 0.06 0.10 0.03 0.01
Emotional discomfort 0.31n 0.32nn 0.05 0.30n
MATRICS
Processing speed 0.34nn 0.14 0.42nnn 0.38nn
Attention 0.12 0.06 0.32nn 0.20
Working memory 0.39nn 0.11 0.29n 0.35nn
Verbal memory 0.34nn 0.02 0.16 0.25
Visual memory 0.34nn 0.12 0.28n 0.32nn
Abstract reasoning 0.32nn 0.03 0.23 0.27
Social cognition 0.21 0.05 0.33nn 0.24
Composite 0.44nnn 0.12 0.46nnn 0.44nnn
TAS-20 Factor 1¼difﬁculty identifying feelings; TAS-20 Factor 2¼difﬁculty describ-
ing feelings; TAS-20 Factor 3¼externally oriented thinking
n p≤0.025.
nn p≤0.01.
nnn po0.001.
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anxiety, and poorer verbal memory. Together, these variables
accounted for 49% of the variance in TAS-20 Factor 1 scores.
Regarding overall level of alexithymia, analyses revealed that
higher alexithymia was predicted by greater efforts at impression
management, poorer processing speed, and more severe anxiety,
accounting for 46% of the variance in TAS-20 total scores.
Finally, to explore the relationship among cognitive and affec-
tive variables from the vantage point of general relationship, we
conducted two standard regressions, this time entering both the
MATRICS total score and PANSS anxiety score to ﬁrst predict the
TAS-20 Factor 1 and then the TAS-20 total. Both regressions were
signiﬁcant (F(4,62)¼8.06, p¼0.001; F(4,62)¼7.78, p¼0.001,
respectively). The beta weights for the MATRICS composite score
were 0.28 (p¼0.02) and 0.27 (p¼0.02) respectively. The beta
weights for the PANSS anxiety score were 0.35 (p¼0.003) and 0.35
(p¼0.003).
4. Discussion
In this study we examined the potential relationships between
alexithymia and neurocognition and symptoms among persons
with schizophrenia spectrum disorders, controlling for impression
management, which is a response style which might affect the
self-report of alexithymia. As predicted, greater levels of alexithy-
mia were generally signiﬁcantly associated with poorer neurocog-
nition, and more speciﬁcally, difﬁculty identifying feelings and
externally oriented thinking were linked with a broad range of
neurocognitive impairments. While we did not ﬁnd signiﬁcant
links between alexithymia and positive or negative symptoms,
consistent with our hypothesis, greater emotional discomfort was
associated with overall level of alexithymia and more speciﬁcally
with difﬁculty identifying and describing feelings. Overall, the link
between emotional discomfort and alexithymia appears to be
accounted for by underlying associations between both anxiety
and depression and alexithymia. When we conducted multiple
regression analyses to examine whether the links of emotional
distress and neurocognitive deﬁcits with alexithymia were inde-
pendent of one another, we found that after controlling for
impression management, working memory, anxiety, and verbal
memory were each signiﬁcant predictors of difﬁculty identifying
feelings, and processing speed and anxiety were both signiﬁcant
predictors of overall level of alexithymia.
While causal inferences cannot be drawn from this cross
sectional data, our results raise several possibilities that can be
the subject of future research. First, it may be that a certain level of
neurocognitive competence is necessary to engage in self-
reﬂective activities, such as the ability to reﬂect on one's emotions.
Based on our ﬁndings, for example, it may be necessary for
persons to be able to hold and manipulate information in memory
before they can pinpoint their affective states. This possibility is
consistent with the broader literature on the interactions between
neurocognition and metacognition (Lysaker et al., 2007, 2010,
2011b), Theory of Mind (Pickup, 2008), and related literature
suggesting alexithymia entails a deﬁcit in thinking about one's
internal states (Dimaggio et al., 2009). Second, while neurocogni-
tive capacities may be needed to identify feelings, the ability to
express feelings may require the absence of emotional distress.
One possibility is that anxiety or depression dampens the ability or
motivation to express feelings. Alternatively, it could be that
disturbances in the ability to express feelings are central and
result in distress. For instance, it is possible that struggling to
translate physiological sensations into an emotion that can be
named could engender a diffuse distressed emotional state like
anxiety or depression. Both possibilities are consistent with recent
ﬁndings linking ﬁrst episode major depression with decrements in
self-reﬂectivity (Ladegaard et al., in press). It is also possible that
observed relationships were the product of other factors not
measured here, such as trauma.
At the very least these ﬁndings suggest that alexithymia in
schizophrenia is a complex phenomenon with distinguishable
connections with disturbances in both affect and cognition. Find-
ings also support the intriguing assertion that perceiving and
expressing one's own emotions are sufﬁciently distinct processes,
with the former in schizophrenia tied to both neurocognition and
distress, and the second tied to distress alone. Beyond that, having
an externalizing orientation shares some of the same associations
as identifying feelings with neurocognition but not with affect.
Another ﬁnding deserving comment concerns the fact that in
our sample greater efforts to present oneself in a favorable light
were linked with lesser reports of alexithymia. As the most
utilized measure of alexithymia (Lumley, 2000; Bagby et al.,
2006), the TAS-20 has been commonly used without controlling
for biases that may arise due to self-report, perhaps because the
measure was reportedly designed to limit such inﬂuences (Bagby
et al., 1994a). While phenomenon such as insight may not be
linked with response style (cf. Bell et al., 2007), it may be that
future work needs to statistically control for such inﬂuences or
utilize alternate measures. Though TAS-20 scores are signiﬁcantly
related to assessments of alexithymia that use clinician interviews,
Meganck et al. (2011) assert that interviews provide a better gauge
of alexithymia. Similarly, Lumley et al. (2005) found that self-
report measures of alexithymia converge with interview ratings,
collateral reports, and performance-based assessments, though
only to a modest degree (r¼0.20–0.30), thus highlighting the
utility of using multi-method assessment or eliminating the use of
self-report measures. Of note, the convergent validity of these
measures was not assessed using samples of persons with schizo-
phrenia. As such, future research may examine convergence of
self-report and other measures of alexithymia within this popula-
tion, and consider using alternate measures, such as the Observer
Alexithymia Scale (OAS; Haviland et al., 2000), the modiﬁed Beth
Israel Hospital Psychosomatic Questionnaire (mBIQ; Taylor et al.,
2000), or the Toronto Structured Interview for Alexithymia (TSIA;
Bagby et al., 2006).
Of note, this study has several limitations. First, this study
utilized a small sample of participants who were predominantly
male and middle-aged given the research setting (Veterans Affairs
medical center). Further, the sample was largely comprised of
persons who had experienced psychosis for long periods of time,
had been hospitalized on numerous occasions, and were at least
somewhat engaged in a treatment setting. As such, it is unclear to
what extent results from the present study apply to younger adults
experiencing psychosis, persons experiencing a ﬁrst-episode, and
those who decline treatment. Given ﬁndings that gender may
affect metacognition (Abu-Akel and Bo, 2013), more work is
needed examining this phenomenon in samples with a greater
representation of women. Affective symptoms were furthermore
Table 3
Stepwise multiple regressions predicting alexithymia from variables found to be
signiﬁcant in univariate correlations.
Signiﬁcant Predictors R2 Total R2 (d.f.) F
TAS-20 Factor 1 Impression management 0.25 0.25 (4,60) 14.62*
Working memory 0.11 0.36
Anxiety 0.08 0.44
Verbal memory 0.05 0.49
TAS-20 Total Impression management 0.28 0.28 (3,61) 17.14*
Processing speed 0.10 0.38
Anxiety 0.08 0.46
n po0.001.
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assessed with single indices, which may be less sensitive than self-
reports which contain multiple items. Future research could
beneﬁt from utilizing larger and more diverse samples in order
to increase conﬁdence in, and generalizability of, the results.
With replication, ﬁndings may have important implications for
clinical work. We found that persons with more signiﬁcant
neurocognitive impairments were more likely to have more severe
alexithymia, raising the possibility that for such persons, certain
treatments may be complicated by both neurocognitive compro-
mise and self-reﬂective deﬁcits. To be speciﬁc, difﬁculties with
memory and identifying feelings could pose challenges for
cognitive-behavioral therapy for schizophrenia, which has been
found to be efﬁcacious, though not for all persons with the
disorder (Rector and Beck, 2012). With less developed or lost
abilities to remember and process speciﬁc events and thoughts,
and identify corresponding emotions, other treatments may be
necessary in order to promote recovery from schizophrenia.
Further, if metacognitive deﬁcits such as alexithymia are vulner-
ability factors to developing psychosis, as hypothesized by several
researchers (e.g., Brüne, 2003; Van’t Wout et al., 2007; van der
Meer et al., 2009; Dimaggio and Lysaker, 2010), alternate treat-
ment approaches also may hold promise for preventing the
emergence of aspects of illness such as symptoms and functional
impairment. As such, it may be useful to consider and further
develop interventions that target alexithymia and neurocognitive
impairments that may make self-reﬂection difﬁcult. Integrative
psychotherapy that targets metacognition could assist persons to
develop these capacities (Hasson-Ohayon, 2012; Lysaker et al.,
2010, 2011a), as has been demonstrated in several studies (e.g.,
Brent, 2009; Buck & Lysaker, 2009; Salvatore et al., 2012), and
cognitive remediation (Bell et al., 2008) could provide the ground-
work necessary for metacognitively focused psychotherapy to be
successful.
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